C ONGESTIVE heart failure is characterized clinically by the presence of circulatory congestion in the vessels leading to either the right heart, the left heart or both; it is this congestion which gives rise to most of the symptoms and physical signs considered diagnostic of congestive heart failure. One of the hypotheses advanced to explain the genesis of this circulatory congestion holds that a primary failure to excrete salt and water leads to the retention of fluid in the vascular system, which in turn produces the characteristic congestion and mnanifestations of congestive heart failure.1' 2, In recent years, there has been increasing evidence that clinical manifestations similar to those ob-in association with fluid retention of noncardiac origin, for example, after daily intravenous infusions of serum albumin,4 during the oliguria of acute glomerulonephritlis,5' 6 following excessive fluid intake in lowert nephron nephrosis7' 8, and during the administration of the salt and water retaining substances, desoxycorticosterone acetate (DCA), corticotropin (ACTH) and cortisone.
It was the purpose of the present study to determine whether marked accumulation of fluid, produced in noncardiac subjects by the administration of salt and water retaining substances, could induce cardiovascular hemodynamic alterations similar to the changes observed in naturally developing congestive heart failure. Such determinations should bear directly upon the various hypotheses of the genesis of congestive heart failure.
,METHODS Cardiovascular dy1cnamic functions dwere determined in the same subjects in the control state and again w-hen maximal fluid accumulation had been produced by the aadministration of corticotropin or cortisone. In approximately one-half of the subHE1HODYNAMIC CHANGES ASSOCIATED WITH FLUID RETENTION completion of the diuresis and weight loss which followed discontinuation of the drug. The following hemodynamic functions were measured: cardiac output bly cardiac catheterization and the direct Fick method;" oxygen consumption by the open method with analysis of exhaled air for oxygen and carbon dioxide by the Beckman oxygen analyzer;12 pressures in the right heart and peripheral systemic artery by direct recording with Hamilton manometers; peripheral systemic venous pressure by saline manometer; oxygen content of arterial and right heart blood by manometric analysis;13 "blood volume''* by the Evans Blue dye (T-1824)t dilution method14 and electrocardiogram by string galvanometer. Body weight was determined daily. Plasma potassium and serum sodium concentrations, measured by flame photometer, were determined on the day of the hemodynamic measurements and once weekly during the period of administration of the drugs. Heart size was estimated by teleoroentgenograms of the chest taken on the day of the hemodynamic measurements.
Hemodynamic determinations were made in the morning after an overnight fast. Three successive sets of measurements were carried out with the subjects supine and at rest. The samples of exhaled air, arterial and mixed venous blood were collected over a three-minute period; the various pressures were recorded during the immediately preceding two-minute "washout" of the Tissot gasometer. The concentration of the dye T-1824 in serum was extrapolated to the time of injection from measurements on samples taken 10, 20, and 30 minutes after injection of the dye. The data presented are the averages of the three individual measurements, except in occasional instances where technical difficulties resulted in fewer determinations. Standard procedures were used in the calculations. The values for surface area were always based on the patient's edema-free weight.
Of the 14 subjects who received corticotropin, seven were convalescing from some intercurrent disease, three had rheumatoid arthritis, one had arthritis other than rheumatoid, one had lupus erythematosus disseminata and two were patients with heart disease who had just recovered from congestive heart failure with bed rest and mercurial diuretics, but without digitalis ( 3). Except for the two known cardiac patients, no subject had evidence of heart dlisease as judged from the history phiysical examination, electroc.aridiogr'ami-i or roentgenographically(determined heart size. No subject was febrile during the period of study and all partook of the usual hospital ward activity. Cortisone was given orally as Cortone acetate and corticotropin as Acthar intramuscularly. The duiration of administration was two to six weeks. The subjects ate the regular hospital diet, without restriction or addition of salt and received 2 Gm. of potassium chloride daily.
RESULTS
Almost every subject gained some weight presumably as flesh and this weight was not lost during the diuresis which followed discontinuation of corticotropin or cortisone. Since the study was focused on the effects of fluid retention, the values for fluid gain in tables 1 and 3 exclude weight gained as flesh and were derived by obtaining the difference between the maximum weight while receiving the drugs and the weight after completion of the diuresis induced by withdrawal of the drugs. Most of the subjects (10 of 14 receiving corticotropin and 3 of the 8 receiving c(ortisone) gained no fluid, or less than five pounds. In this category are the two undigitalized cardiac subjects who received corticotropin shortly after recovering from congestive heart failure. Five subjects, one receiving corticotropin and four cortisone, gained moderate amounts of fluid, from 9 to 14 pounds. Four subjects, three receiving corticotropin and one cortisone, gained considerable amounts of fluid, 16 to 23 pounds. Only these subjects presented clinical manifestations in any way suggesting congestive heart failure. Serum sodium and plasma potassium concentrations remained essentially unchanged in all subjects. Since the hemodynamic alterations produced by corticotropin and cortisone were largely similar, the changes produced by the two substances will be considered together.
Minimal Fluid Retention. When fluid gain was absent or small, less than 5 pounds, alterations in hemodynamic functions were likewise absent or small (tables 1, 2, 3, 4 and fig. 1 ). The most frequent change was a small increase in the residual pressures in the right heart, greater in right ventricular end diastolic pressure than in dyspnea on exertion and orthopnea of sufficient degree to make sleep at night a little difficult. The clinical manifestations were consistent with mild congestive heart failure. In these three subjects the heart size increased appreciably and congestive changes (rales) appeared in the lungs ( fig. 2 ). The electrocardiogram remained unchanged, except for occasional ventricular premature contractions in subject T. M. for several days at the height of the fluid gain. All of the above manifestations disappeared and the control state returned after completion of the diuresis which followed discontinuation of corticotropin or cortisone.
The marked fluid retention in these three subjects was associated with increases in vascular pressures and "blood volume" but without change in cardiac output. The in- For each subject the first set of determinations are control, the second set at peak of cortisone effect. Because the hematocrit fell during administration of corticotropin, the third set of determinations was made after the diuresis which followed discontinuation of the drug. This set of determinations constitutes the preferred control for the changes induced by the corticotropin. 0.8 mg. of Digoxin intravenously without effect upon the elevated venous pressure of 170 to 180 mm. saline. Starting three hours later, 1.0 Gm. of digitalis leaf was given orally in 24 hours without reduction in the still elevated venous pressure and without initiation of diuresis or relief of symptoms, events which would have been expected in a patient with congestive heart failure. Only after corticotropin was discontinued did a diuresis with a concomitant fall in venous pressure and relief of symptoms ensue.
DIscuSSION
The observations presented suggest three points for discussion: (1) the disparity in fluid accumulation by different subjects, (2) the increase in pressure in the right heart and systemic arteries when fluid accumulation occurred and (3) the circulatory dynamics in No explanation is apparent for the disparit in fluid gains by the different subjects. Th degree of fluid retention appeared not to b related to the primary illness of the subject their state of convalescence, or whethE corticotropin or cortisone was given. Althoug observations were not made in completel normal subjects, it seems unlikely that th subjects who retained large amounts of flui had "hidden" or potential heart disease. In ii subject, except the two known cardiac patient was there evidence of heart disease. Furthe more, the failure of the two undigitalize cardiac patients, recently recovered from coi gestive heart failure, to retain more than min mal amounts of fluid suggests that some fori of heart disease is not essential for the flui retention. Apparently, homeostatic mecht nisms promoting salt and water excretion are E potent that few subjects receiving these sa and water retaining drugs, in the doses use( retain sufficient fluid to become so edematoi 1053 that congestive changes simulating congestive heart failure develop.
The most consistent hemodynamic change induced by both corticotropin and cortisone was the increase in pressure in all parts of the vascular tree. A first consideration would suggest that the pressure elevations resulted from an increase in blood volume with subsequent overdistension of the venous reservoir and right heart. However, the failure of correlation between increases in vascular pressures and changes in "blood volume" (table 5) suggests that "blood volume" is not the sole determinant of changes in pressure and that an additional factor is probably operating. A possible and attractive explanation would be that corticotropin and cortisone increased the vascular tone of the entire vascular system from arteries to veins and right heart. Such an increase in tonus could produce two effects: (1) raise the h pressure in all parts of the vascular system and of (2) redistribute the blood from the higher 1. toned arterial and arteriolar side to the lesser toned, and more distensible venous side. These No explanation is offered for the mechanism by which cortisone or corticotropin might increase vascular tone. The first observations were made with corticotropin and the possibility was entertained that contaminating Pitressin may have been responsible for the observed pressor effects. When cortisone produced similar increments in pressure it seemed unlikely that a contaminating known vasopressor agent was responsible for the increases in pressures. Since the rises in residual pressures in the right heart seemed to correlate better with the degree of fluid gain than with the increase in "blood volume" (table 5), the possibility should be considered that salt itself may have been the pressor agent. Neither cortisone nor corticotropin in themselves appear to possess vasopressor activity, for equally large doses, when they failed to induce fluid retention, failed also to produce rises in vascular pressures.
Since it was the purpose of this study to determine whether induced fluid retention in noncardiac subjects was associated with hemodynamic changes similar to, or different from, the hemodynamic alterations of spontaneously developing congestive heart failure, the changes in cardiovascular dynamics in the subjects with marked fluid retention deserve particular attention. In three respects the changes noted in these subjects were similar to the maniifestations of naturally occurring congestive heart failure: (1) there developed the symptoms of edema, exertional dyspnea and orthopniea, (2) the "blood volume" was increased and (3) the residual pressures (atrial and ventricular end diastolic) in the right heart were elevated. The increase in right ventricular end diastolic pressure assumes particular significance since elevration of this pressure has been considered to be the criterion of congestive heart failure.'6 However, each of the above three manifestations may be considered to be nonspecific, or secondary in origin, in that they are the resultants of some other more primary physiologic change or changes. Therefore, the presence of these manifestations in two states does not necessarily indicate that both states are simiilarly derived.
The hemodynamiic alterations associated with induced fluid retention differed markedly from the hemodynamic changes ill congestive heart failure in several important, primary, cardiodynamic functions. Thus, in both the corticotropin-and cortisone-induced congestion, cardiac output remained normal and arterial-mixed venous oxygen extraction, relating as it does blood supply (cardiac output) to the demand for it (oxygen consumption), also remained normal. Ill congestive heart failure the changes in these functions are diametrically different: cardiac output is reduced and arteriovenous oxygen difference is abnormally high. Furthermiore, the failure of intra- Three subjects gained 16, 19 and 23 pounds of fluid, respectively, became edematous, developed slight cardiac enlargement and manifested in a mild form the symptoms of (conigestive heart failure. The associated hemodynamic changes of elevation of pressures in the right heart and systemic arteries and increases in "blood volume" were similar to the changes in these functions in congestive heart failure; however, unlike congestive heart failure, cardiac output and arteriovenous oxygen difference remained normal.
Two cardiac subjects, recently "(compenisated" from congestive heart failure by mercurial diuretics and rest, failel to gain fluid when given corticotropin.
In discussion, the hypothesis is explored that the circulatory congestion associated with marked fluid retention in nlollcardiac subjects represeiits not congestive heart failure, but a type of noncardiac circulatory congestion which simulates congestive heart failure. The 
